Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Income to Minority Interest
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Income to Minority Interest Peer Comparison
Competitive Income to Minority Interest Analysis
Latest Figures & CAGR of Competitors
Company | Income to Minority Interest | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
Income to Minority Interest
-¥216.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-21%
|
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
Income to Minority Interest
-¥199.4m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Income to Minority Interest
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Income to Minority Interest
-¥51.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-50%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Income to Minority Interest
¥20.3m
|
CAGR 3-Years
25%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Income to Minority Interest
-¥28.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-40%
|
See Also
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Income to Minority Interest?
Income to Minority Interest
-216.8m
CNY
Based on the financial report for Mar 31, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Income to Minority Interest amounts to -216.8m CNY.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Income to Minority Interest growth rate?
Income to Minority Interest CAGR 10Y
-21%
Over the last year, the Income to Minority Interest growth was 17%. The average annual Income to Minority Interest growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been -7% over the past three years , -11% over the past five years , and -21% over the past ten years .